Cargando…

A possible injectable tissue engineered nucleus pulposus constructed with platelet-rich plasma and ADSCs in vitro

BACKGROUND: Injectable tissue engineered nucleus pulposus is a new idea for minimally invasive repair of degenerative intervertebral disc. The platelet-rich plasma (PRP) and adipose-derived stromal cells (ADSCs) could be harvested from autologous tissue easily. PRP contains numerous autologous growt...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, ZhiCheng, Ma, Jian, Ren, DaJiang, Li, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414651/
https://www.ncbi.nlm.nih.gov/pubmed/32771036
http://dx.doi.org/10.1186/s13018-020-01840-1
_version_ 1783569011986923520
author Zhang, ZhiCheng
Ma, Jian
Ren, DaJiang
Li, Fang
author_facet Zhang, ZhiCheng
Ma, Jian
Ren, DaJiang
Li, Fang
author_sort Zhang, ZhiCheng
collection PubMed
description BACKGROUND: Injectable tissue engineered nucleus pulposus is a new idea for minimally invasive repair of degenerative intervertebral disc. The platelet-rich plasma (PRP) and adipose-derived stromal cells (ADSCs) could be harvested from autologous tissue easily. PRP contains numerous autologous growth factors and has reticulate fibrous structure which may have the potential to make ADSCs differentiate into nucleus pulposus-like cells. The goal of this study was to explore the feasibility of constructing a possible injectable tissue engineered nucleus pulposus with PRP gel scaffold and ADSCs. METHODS: After identification with flow cytometry, the rabbit ADSCs were seeded into PRP gel and cultured in vitro. At the 2nd, 4th, and 8th week, the PRP gel/ADSCs complex was observed by macroscopy, histological staining, BrdU immunofluorescence, and scanning electron microscopy. The glycosaminoglycans (GAG) in the PRP gel/ADSCs complex were measured by safranin O staining with spectrophotometry. In PRP gel/ADSCs complex, gene expression of HIF-1α, aggrecan, type II collagen were tested by RT-PCR. The injectability of this complex was evaluated. RESULTS: Macroscopically, the complex was solidified into gel with smooth surface and good elasticity. The safranin O dye was almost no positive staining at 2nd week; however, the positive staining of extracellular matrix was enhanced obviously at 4th and 8th week. The HE staining and SEM demonstrated that the cells were well-distributed in the reticulate scaffold. BrdU immunofluorescence showed that ADSCs can survive and proliferate in PRP gel at each time points. The level of GAG at 4th week was higher than those at 2nd week (P < 0.05), and significant difference was also noted between 4th and 8th week (P < 0.05). HIF-1α, aggrecan, type II collagen gene expression at 4th week were much more than those at 2nd week (P < 0.05), and significant differences were also noted between 4th and 8th week (P < 0.05). The flow rate of complex was 0.287 mL/min when passed through the 19-gauge needle with the 100 mmHg injection pressure. CONCLUSIONS: Our preliminary findings suggest that the PRP gel make it possible for rabbit ADSCs differentiated into nucleus pulposus-like cells after coculture in vitro. According to the results, it is a better feasible method for construction of autologous injectable tissue engineered nucleus pulposus.
format Online
Article
Text
id pubmed-7414651
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74146512020-08-10 A possible injectable tissue engineered nucleus pulposus constructed with platelet-rich plasma and ADSCs in vitro Zhang, ZhiCheng Ma, Jian Ren, DaJiang Li, Fang J Orthop Surg Res Research Article BACKGROUND: Injectable tissue engineered nucleus pulposus is a new idea for minimally invasive repair of degenerative intervertebral disc. The platelet-rich plasma (PRP) and adipose-derived stromal cells (ADSCs) could be harvested from autologous tissue easily. PRP contains numerous autologous growth factors and has reticulate fibrous structure which may have the potential to make ADSCs differentiate into nucleus pulposus-like cells. The goal of this study was to explore the feasibility of constructing a possible injectable tissue engineered nucleus pulposus with PRP gel scaffold and ADSCs. METHODS: After identification with flow cytometry, the rabbit ADSCs were seeded into PRP gel and cultured in vitro. At the 2nd, 4th, and 8th week, the PRP gel/ADSCs complex was observed by macroscopy, histological staining, BrdU immunofluorescence, and scanning electron microscopy. The glycosaminoglycans (GAG) in the PRP gel/ADSCs complex were measured by safranin O staining with spectrophotometry. In PRP gel/ADSCs complex, gene expression of HIF-1α, aggrecan, type II collagen were tested by RT-PCR. The injectability of this complex was evaluated. RESULTS: Macroscopically, the complex was solidified into gel with smooth surface and good elasticity. The safranin O dye was almost no positive staining at 2nd week; however, the positive staining of extracellular matrix was enhanced obviously at 4th and 8th week. The HE staining and SEM demonstrated that the cells were well-distributed in the reticulate scaffold. BrdU immunofluorescence showed that ADSCs can survive and proliferate in PRP gel at each time points. The level of GAG at 4th week was higher than those at 2nd week (P < 0.05), and significant difference was also noted between 4th and 8th week (P < 0.05). HIF-1α, aggrecan, type II collagen gene expression at 4th week were much more than those at 2nd week (P < 0.05), and significant differences were also noted between 4th and 8th week (P < 0.05). The flow rate of complex was 0.287 mL/min when passed through the 19-gauge needle with the 100 mmHg injection pressure. CONCLUSIONS: Our preliminary findings suggest that the PRP gel make it possible for rabbit ADSCs differentiated into nucleus pulposus-like cells after coculture in vitro. According to the results, it is a better feasible method for construction of autologous injectable tissue engineered nucleus pulposus. BioMed Central 2020-08-08 /pmc/articles/PMC7414651/ /pubmed/32771036 http://dx.doi.org/10.1186/s13018-020-01840-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Zhang, ZhiCheng
Ma, Jian
Ren, DaJiang
Li, Fang
A possible injectable tissue engineered nucleus pulposus constructed with platelet-rich plasma and ADSCs in vitro
title A possible injectable tissue engineered nucleus pulposus constructed with platelet-rich plasma and ADSCs in vitro
title_full A possible injectable tissue engineered nucleus pulposus constructed with platelet-rich plasma and ADSCs in vitro
title_fullStr A possible injectable tissue engineered nucleus pulposus constructed with platelet-rich plasma and ADSCs in vitro
title_full_unstemmed A possible injectable tissue engineered nucleus pulposus constructed with platelet-rich plasma and ADSCs in vitro
title_short A possible injectable tissue engineered nucleus pulposus constructed with platelet-rich plasma and ADSCs in vitro
title_sort possible injectable tissue engineered nucleus pulposus constructed with platelet-rich plasma and adscs in vitro
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414651/
https://www.ncbi.nlm.nih.gov/pubmed/32771036
http://dx.doi.org/10.1186/s13018-020-01840-1
work_keys_str_mv AT zhangzhicheng apossibleinjectabletissueengineerednucleuspulposusconstructedwithplateletrichplasmaandadscsinvitro
AT majian apossibleinjectabletissueengineerednucleuspulposusconstructedwithplateletrichplasmaandadscsinvitro
AT rendajiang apossibleinjectabletissueengineerednucleuspulposusconstructedwithplateletrichplasmaandadscsinvitro
AT lifang apossibleinjectabletissueengineerednucleuspulposusconstructedwithplateletrichplasmaandadscsinvitro
AT zhangzhicheng possibleinjectabletissueengineerednucleuspulposusconstructedwithplateletrichplasmaandadscsinvitro
AT majian possibleinjectabletissueengineerednucleuspulposusconstructedwithplateletrichplasmaandadscsinvitro
AT rendajiang possibleinjectabletissueengineerednucleuspulposusconstructedwithplateletrichplasmaandadscsinvitro
AT lifang possibleinjectabletissueengineerednucleuspulposusconstructedwithplateletrichplasmaandadscsinvitro